Previous close | 82.46 |
Open | 82.35 |
Bid | 82.89 x 1000 |
Ask | 87.00 x 800 |
Day's range | 82.23 - 83.62 |
52-week range | 57.55 - 83.73 |
Volume | |
Avg. volume | 696,745 |
Market cap | 8.292B |
Beta (5Y monthly) | 0.83 |
PE ratio (TTM) | 23.00 |
EPS (TTM) | 3.60 |
Earnings date | 25 Apr 2024 |
Forward dividend & yield | 0.60 (0.73%) |
Ex-dividend date | 28 Mar 2024 |
1y target est | 89.20 |
The headline numbers for Encompass Health (EHC) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Robust Discharge Growth and Effective Expense Management Drive Strong Q1 Performance
Encompass Health Corporation (NYSE: EHC), the largest owner and operator of inpatient rehabilitation hospitals in the United States, today reported its results of operations for the first quarter ended March 31, 2024.